Skip to main content
. 2017 Sep 22;61(10):e00906-17. doi: 10.1128/AAC.00906-17

TABLE 1.

Activity of antifungal agents tested using the CLSI reference broth microdilution method against fungal organism groups according to clinical breakpoints and/or ECV interpretative criteriaa

Organism (no. of isolates tested) and antifungal agent MIC50 or MEC50 (μg/ml) MIC90 or MEC90 (μg/ml) % of isolates
CLSI method
ECV
S R WT NWT
C. albicans (1,310)
    Anidulafungin 0.015 0.03 99.9 0.0 99.8 0.2
    Caspofungin 0.015 0.03 99.8 0.2
    Micafungin 0.015 0.03 99.8 0.2 99.8 0.2
    Fluconazole ≤0.12 0.25 99.6 0.4
    Voriconazole ≤0.008 0.015 99.9 <0.1
    Posaconazole 0.03 0.06
    Amphotericin B 1 1 100.0 0.0
C. glabrata (514)
    Anidulafungin 0.06 0.12 95.9 2.5 97.5 2.5
    Caspofungin 0.03 0.06 96.9 2.5
    Micafungin 0.015 0.03 97.5 2.3 96.9 3.1
    Fluconazole 4 16 92.0b 8.0
    Voriconazole 0.12 0.5
    Posaconazole 0.5 1
    Amphotericin B 1 1 100.0 0.0
C. parapsilosis (417)
    Anidulafungin 2 4 88.7 0.0 100.0 0.0
    Caspofungin 0.25 0.5 100.0 0.0
    Micafungin 1 2 100.0 0.0 100.0 0.0
    Fluconazole 0.5 2 95.7 3.8
    Voriconazole 0.015 0.03 96.4 0.7
    Posaconazole 0.06 0.12
    Amphotericin B 1 1 100.0 0.0
C. tropicalis (264)
    Anidulafungin 0.015 0.03 100.0 0.0 100.0 0.0
    Caspofungin 0.015 0.06 100.0 0.0
    Micafungin 0.015 0.06 100.0 0.0 99.6 0.4
    Fluconazole 0.25 0.5 96.2 2.7 96.2 3.8
    Voriconazole 0.015 0.06 97.0 2.3
    Posaconazole 0.03 0.12
    Amphotericin B 1 1 100.0 0.0
C. krusei (93)
    Anidulafungin 0.06 0.12 100.0 0.0 100.0 0.0
    Caspofungin 0.12 0.25 100.0 0.0
    Micafungin 0.06 0.12 100.0 0.0 100.0 0.0
    Fluconazole 32 64
    Voriconazole 0.25 0.5 100.0 0.0
    Posaconazole 0.25 0.5
    Amphotericin B 1 2 100.0 0.0
C. dubliniensis (58)
    Anidulafungin 0.03 0.12 100.0 0.0
    Caspofungin 0.03 0.06
    Micafungin 0.03 0.06 100.0 0.0
    Fluconazole ≤0.12 0.25
    Voriconazole ≤0.008 0.015
    Posaconazole 0.03 0.06
    Amphotericin B 0.5 1
C. lusitaniae (39)
    Anidulafungin 0.25 0.5 100.0 0.0
    Caspofungin 0.12 0.25
    Micafungin 0.12 0.25 100.0 0.0
    Fluconazole 0.5 1
    Voriconazole ≤0.008 ≤0.008
    Posaconazole 0.06 0.12
    Amphotericin B 0.5 1
C. guilliermondii (14)
    Anidulafungin 2 4 92.9 0.0 100.0 0.0
    Caspofungin 0.5 1 100.0 0.0
    Micafungin 1 1 100.0 0.0 100.0 0.0
    Fluconazole 2 64
    Voriconazole 0.06 1
    Posaconazole 0.5 >8
    Amphotericin B 0.25 1
A. fumigatus (391)
    Anidulafungin ≤0.008 0.03
    Caspofungin 0.015 0.03 100.0 0.0
    Micafungin ≤0.008 0.015
    Itraconazole 0.5 1 99.5 0.5
    Voriconazole 0.5 0.5 99.7 0.3
    Posaconazole 0.25 0.5
    Amphotericin B 1 2 100.0 0.0
A. niger (15)
    Anidulafungin ≤0.008 0.03
    Caspofungin 0.015 0.03 100.0 0.0
    Micafungin ≤0.008 0.015
    Itraconazole 0.5 1 100.0 0.0
    Voriconazole 0.5 0.5 100.0 0.0
    Posaconazole 0.25 0.5 100.0 0.0
    Amphotericin B 1 2 100.0 0.0
A. terreus (12)
    Anidulafungin ≤0.008 0.03
    Caspofungin 0.015 0.03 100.0 0.0
    Micafungin ≤0.008 0.015
    Itraconazole 0.5 1 100.0 0.0
    Voriconazole 0.5 0.5 100.0 0.0
    Posaconazole 0.25 0.5 100.0 0.0
    Amphotericin B 1 2 100.0 0.0
a

MEC50 and MEC90, minimum effective concentrations for 50% and 90% of isolates, respectively; CLSI, Clinical and Laboratory Standards Institute; S, susceptible; R, resistant; ECV, epidemiologic cutoff value; WT, wild-type; NWT, non-wild-type.

b

Susceptible dose dependent.